Clik here to view.
New University of Alberta-based study to examine very rare adverse events...
The multimillion-dollar global initiative will study causes and risk factors, to ensure safer vaccines are ready for the next potential pandemic. EDMONTON — A University of Alberta professor is...
View ArticleThrombosis with Thrombocytopenia Syndrome (TTS) and Vaccine-Induced Immune...
This is a revision of the online November 2021 Brighton thrombosis with thrombocytopenia syndrome (TTS) case definition and a new Brighton Collaboration case definition for vaccine-induced immune...
View ArticleRequest for Review: Standardized template with key considerations for a...
The proposed mRNA BioNTech/Comirnaty manuscript is ready for peer review. The Brighton Collaboration BRAVATO (Benefit-Risk Assessment of VAccines by TechnolOgy) Working Group encourages the Brighton...
View ArticleSafety by Numbers – February 2024
Access the February 2024 issue of Safety by Numbers here > The post Safety by Numbers – February 2024 appeared first on Brighton Collaboration.
View Article99 Million People Included in Largest Global Vaccine Safety Study
Global Vaccine Data Network utilises vast data sets to detect potential vaccine safety signals 19 February 2024—The Global Vaccine Data Network (GVDN) assessed 13 neurological, blood, and heart related...
View ArticleClik here to view.
COVID-19 Safety Studies project offers evidence to support increasing active...
Vaccine safety data can help build public confidence in vaccines by communicating that the benefits outweigh the risks of immunization. Through the COVID-19 Safety Studies project, researchers aimed...
View ArticleAutoimmune Hepatitis
This report introduces a Brighton Collaboration (BC) case definition for autoimmune hepatitis (AIH), which has been classified as a priority adverse event of special interest (AESI), as there were...
View ArticleLessons Learned and Key Recommendations from the COVAX Vaccine Safety Working...
The Vaccine Safety Working Group (VSWG) of COVAX was formed in November 2020 with representatives and consultants representing multiple stakeholders, including Brighton Collaboration, Developing...
View ArticleClik here to view.
Dr. Eileen Farnon joins Brighton Collaboration as Research Director
Dr. Eileen Farnon, Research Director at Brighton Collaboration The Task Force for Global Health welcomes Dr. Eileen Farnon as Brighton Collaboration’s new Research Director. Dr. Farnon, who is trained...
View ArticleVSQ Q1 2024
The 2024 Quarter 1 issue of Brighton Collaboration’s Vaccine Safety Quarterly is available below. Read the Vaccine Safety Quarterly Q1 2024 The post VSQ Q1 2024 appeared first on Brighton Collaboration.
View Article
